ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 432

Identification and Characterization of Fibrinogen-Specific T Cells in Patients with Rheumatoid Arthritis

Laura Su1 and Mark M. Davis2, 1The Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 2Department of Microbiology and Immunlogy and Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: T cells and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenisis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is a common, highly debilitating systemic inflammatory condition. To date, little is known about which autoantigens are involved in RA and how T cells which recognize self-proteins may become pathogenic in disease.  Fibrinogen is a common target of autoantibodies in RA patients, and a putative T cell autoantigen involved in disease development.  The goal of this study is to identify and characterize fibrinogen-specific CD4+T cells.

Methods: Autoantigen-specific T cells were identified directly ex vivousing peptide-MHC tetramers. To identify individuals carrying the HLA-DRB1*0401 (DR4) allele, HLA typing was performed on healthy blood donors and RA patients using sequence-specific primer PCR.  To identify antigen-specific T cells, tetramer staining was performed at room temperature for 1 hour using tetramers loaded with several fibrinogen peptides.  Memory phenotyping was performed using antibodies against CD45RO and CCR7.  Tetramer tagged cells were magnetically enriched and analyzed by flow cytometry.  Single cell TCR amplification and sequencing was performed to trace T cell clonality. 

Results: We identified several populations of T cells recognizing citrullinated and uncitrullinated fibrinogen peptides.  The frequency of fibrinogen-specific T cells in RA patients ranges between 3 to 19 per million CD4+T cells.  Many of these lymphocytes express the memory marker CD45RO, particularly among cells that recognize citrullinated forms of the fibrinogen peptides. Examination of the same antigen-specificities in healthy people demonstrated that the frequency and memory characteristics of these cells appear similar in individuals without disease. Moreover, we also found in some healthy people the presence of clonally expanded T cells that recognize citrullinated fibrinogen. 

Conclusion: T cells that recognize citrullinated fibrinogen can be detected in the peripheral blood of RA patients and healthy individuals.  These fibrinogen-specific populations contain large numbers of antigen-experienced T cells with some showing evidence of clonal expansion.


Disclosure:

L. Su,
None;

M. M. Davis,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-and-characterization-of-fibrinogen-specific-t-cells-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology